Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials.
      QxMD      Google Scholar   
Citation:
JCO Precis Oncol vol 4
Year:
2020
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
https://ascopubs.org/doi/10.1200/PO.19.00237
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
9
Parents:
3078  
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
BMS, Pfizer, Sanofi Aventis  
Grants:
U10CA180821, U10CA180882, U24CA196171; R01 CA210509-01A1,  
Corr. Author:
 
Authors:
                                   
Networks:
LAPS-MN026, LAPS-OH007   
Study
NCCTG-N0147
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: